|
1. Aamodt, R., Bondi, J., Andersen, S. N., Bakka, A., Bukholm, G., and Bukholm, I. R. The Prognostic Impact of Protein Expression of E-Cadherin-Catenin Complexes Differs between Rectal and Colon
Carcinoma. Gastroenterol Res Pract (2010).
2. Aksoy, F., Veyseller, B., Binay, O., Apuhan, T., Yildirim, Y. S., and Ozturan, O. [Patterns of cervical metastasis from squamous cell carcinoma of the head and neck]. Kulak Burun Bogaz Ihtis Derg 20, 249-254. (2010).
3. Alshenawy, H. A. Immunohistochemical expression of epidermal growth factor receptor, E-cadherin, and matrix metalloproteinase-9 in ovarian epithelial cancer and relation to patient deaths. Ann Diagn
Pathol 14, 387-395.(2010).
4. Alves Pereira, K. M., do Amaral, B. A., dos Santos, B. R., Galvao, H. C., Freitas Rde, A., and de Souza, L. B. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and
tooth germs. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109, 425-431. (2010).
5. Angelillo-Scherrer, A., de Frutos, P., Aparicio, C., Melis, E., Savi, P., Lupu, F., Arnout, J., Dewerchin, M., Hoylaerts, M., Herbert, J., et al.. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 7, 215-221. (2001).
6. Aresu, L., Pregel, P., Zanetti, R., Caliari, D., Biolatti, B., and Castagnaro, M. E-cadherin and beta-catenin expression in canine colorectal adenocarcinoma. Res Vet Sci 89, 409-414. (2010).
7. Avilla, E., Guarino, V., Visciano, C., Liotti, F., Svelto, M., Krishnamoorthy, G., Franco, R., and Melillo, R. M. Activation of TYRO3/AXL Tyrosine Kinase Receptors in Thyroid Cancer. Cancer Res 71, 1792-1804. (2011).
8. Bae, J. H., Lew, E. D., Yuzawa, S., Tome, F., Lax, I., and Schlessinger, J. The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site. Cell 138, 514-524. (2009)
9. Benvenuti, S., and Comoglio, P. M. The MET receptor tyrosine kinase in invasion and metastasis. J Cell Physiol 213, 316-325. (2007).
10. Benzakour, O., Gely, A., Lara, R., and Coronas, V. [Gas-6 and protein S: vitamin K-dependent factors and ligands for the TAM tyrosine kinase receptors family]. Med Sci (Paris) 23, 826-833. (2007). 76
11. Berney, D. M. The tumour-node-metastasis staging of prostate cancer in transurethral resection of the prostate chips requires revision. BJU Int 107, 351-352. (2011).
12. Bonavida, B., and Baritaki, S. Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-kappaB/Snail/YY1/RKIP circuitry. Nitric Oxide 24, 1-7. (2011).
13. Braunger, J., Schleithoff, L., Schulz, A. S., Kessler, H., Lammers, R., Ullrich, A., Bartram, C. R., and Janssen, J. W. Intracellular signaling of the Ufo/Axl receptor tyrosine kinase is mediated mainly by a multi-substrate docking-site. Oncogene 14, 2619-2631. (1997).
14. Budagian, V., Bulanova, E., Orinska, Z., Thon, L., Mamat, U., Bellosta, P., Basilico, C., Adam, D., Paus, R., and Bulfone-Paus, S. A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control. EMBO J 24, 4260-4270. (2005).
15. Burke, J. M., Cao, F., and Irving, P. E. High levels of E-/P-cadherin: correlation with decreased apical polarity of Na/K ATPase in bovine RPE cells in situ. Invest Ophthalmol Vis Sci 41, 1945-1952. (2000).
16. Cano, A., Perez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., and Nieto, M. A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2, 76-83. (2000).
17. Cano, C. E., and Iovanna, J. L. Stress proteins and pancreatic cancer metastasis. ScientificWorldJournal 10, 1958-1966. (2010).
18. Casas, E., Kim, J., Bendesky, A., Ohno-Machado, L., Wolfe, C. J., and Yang, J. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res 71, 245-254. (2011).
19. Chao, Y. L., Shepard, C. R., and Wells, A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9, 179. (2010).
20. Chen, Z. L., Zhao, X. H., Wang, J. W., Li, B. Z., Wang, Z., Sun, J., Tan, F. W., Ding, D. P., Xu, X. H., Zhou, F., et al. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell
carcinoma via E-cadherin. J Biol Chem. (2010).
21. Cosemans, J. M., Van Kruchten, R., Olieslagers, S., Schurgers, L. J., Verheyen, F. K., Munnix, I. C., Waltenberger, J., Angelillo-Scherrer, A., Hoylaerts, M. F., Carmeliet, P., and Heemskerk, J. W. Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and 77 murine platelet activation and thrombus stabilization. J Thromb Haemost 8, 1797-1808. (2010).
22. Deplazes, J., Fuchs, M., Rauser, S., Genth, H., Lengyel, E., Busch, R., and Luber, B. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation. Hum Mol
Genet 18, 3632-3644. (2009)
23. Dian, D., Bruning, A., and Mylonas, I. E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis. Arch Gynecol Obstet. (2010)
24. Ekman, C., Gottsater, A., Lindblad, B., and Dahlback, B. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin Biochem
43, 873-876. (2010a).
25. Ekman, C., Jonsen, A., Sturfelt, G., Bengtsson, A. A., and Dahlback, B. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology (Oxford).
(2011).
26. Ekman, C., Stenhoff, J., and Dahlback, B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 8, 838-844. (2010b).
27. Fidler, I. J., Balasubramanian, K., Lin, Q., Kim, S. W., and Kim, S. J. The brain microenvironment and cancer metastasis. Mol Cells 30, 93-98. (2010).
28. Gavert, N., Vivanti, A., Hazin, J., Brabletz, T., and Ben-Ze'ev, A. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res 9, 14-24. (2011).
29. Gjerdrum, C., Tiron, C., Hoiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Li, S., McCormack, E., Gjertsen, B. T., et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci U S
A 107, 1124-1129. (2010).
30. Goruppi, S., Ruaro, E., and Schneider, C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 12, 471-480. (1996)
31. Gustafsson, A., Bostrom, A. K., Ljungberg, B., Axelson, H., and Dahlback, B. Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma. PLoS One 4, e7575. (2009).
32. Hafizi, S., Gustafsson, A., Stenhoff, J., and Dahlback, B. The Ran 78 binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases. Int J Biochem Cell Biol 37, 2344-2356. (2005).
33. Hector, A., Montgomery, E. A., Karikari, C., Canto, M., Dunbar, K. B., Wang, J. S., Feldmann, G., Hong, S. M., Haffner, M. C., Meeker, A. K., et al. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma. Cancer
Biol Ther 10, 1009-1018. (2010).
34. Heupel, W. M., Baumgartner, W., Laymann, B., Drenckhahn, D., and Golenhofen, N. Different Ca2+ affinities and functional implications of the two synaptic adhesion molecules cadherin-11 and N-cadherin. Mol Cell Neurosci 37, 548-558. (2008).
35. Hong, C. C., Lay, J. D., Huang, J. S., Cheng, A. L., Tang, J. L., Lin, M. T., Lai, G. M., and Chuang, S. E. Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia. Cancer Lett 268, 314-324. (2008).
36. Hu, F., Wang, C., Guo, S., Sun, W., Mi, D., Gao, Y., Zhang, J., Zhu, T., and Yang, S. deltaEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
Biochim Biophys Acta 1809, 200-210. (2011).
37. Hurtado, B., Munoz, X., Recarte-Pelz, P., Garcia, N., Luque, A., Krupinski, J., Sala, N., and Garcia de Frutos, P. Expression of the vitamin K-dependent proteins GAS6 and protein S and the TAM
receptor tyrosine kinases in human atherosclerotic carotid plaques. Thromb Haemost 105. (2011).
38. Inagaki, Y., Tang, W., Xu, H., Nakata, M., Mafune, K., Konishi, T., Seto, Y., and Kokudo, N. Sustained Aberrant Localization of KL-6 Mucin and {beta}-Catenin at the Invasion Front of Human Gastric
Cancer Cells. Anticancer Res 31, 535-542. (2011).
39. Ishii, K., Shimoda, M., Sugiura, T., Seki, K., Takahashi, M., Abe, M., Matsuki, R., Inoue, Y., and Shirasuna, K. Involvement of epithelial-mesenchymal transition in adenoid cystic carcinoma metastasis. Int J Oncol 38, 921-931. (2011).
40. Jang, M. J., Baek, S. H., and Kim, J. H. UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction. Cancer Lett 302, 128-135. (2011).
41. Kawahara, T., Ohshiro, H., Sekiguchi, Z., Furuya, M., Namura, K., Itoh, H., Sano, F., Kawaji, K., Hayashi, N., Makiyama, K., et al. 79 Gallbladder Metastasis from Renal Cell Carcinoma. Case Rep Oncol 3, 30-34. (2010).
42. Knudsen, K. A., Lin, C. Y., Johnson, K. R., Wheelock, M. J., Keshgegian, A. A., and Soler, A. P. Lack of correlation between serum levels of E- and P-cadherin fragments and the presence of breast
cancer. Hum Pathol 31, 961-965. (2000).
43. Kodama, M., Kodama, T., and Murakami, M. Oncogene activation and tumor suppressor gene inactivation find their sites of expression in the changes in time and space of the age-adjusted cancer incidence rate. In Vivo 14, 725-734. (2000).
44. Koo Ha, H., Jun Park, H., and Cheol Park, N. Expression of E-cadherin and alpha-catenin in a varicocele-induced infertility rat model. Asian J Androl. (2011).
45. Koorstra, J. B., Karikari, C. A., Feldmann, G., Bisht, S., Rojas, P. L., Offerhaus, G. J., Alvarez, H., and Maitra, A. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. Cancer Biol Ther 8, 618-626.
(2009).
46. Korshunov, V. A., Mohan, A. M., Georger, M. A., and Berk, B. C. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 98, 1446-1452. (2006).
47. Kudo-Saito, C., Shirako, H., Takeuchi, T., and Kawakami, Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell 15, 195-206. (2009).
48. Lam, D. K., and Schmidt, B. L. Orofacial pain onset predicts transition to head and neck cancer. Pain. (2011).
49. Lee, C. H., Lee, K. W., Fang, F. M., Wu, D. C., Shieh, T. Y., Huang, H. L., Chen, C. H., Chen, P. H., Chen, M. K., Kuo, S. J., et al. The use of tobacco-free betel-quid in conjunction with alcohol/tobacco impacts early-onset age and carcinoma distribution for upper aerodigestive tract cancer. J Oral Pathol Med. (2011).
50. Lee, E. J., Whang, J. H., Jeon, N. K., and Kim, J. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses proliferation and invasion of human oral squamous
carcinoma cells via p53 independent and MMP, uPAR dependent mechanism. Ann N Y Acad Sci 1095, 113-128. (2007).
51. Levi, M. E., and Eusterman, V. D. Oral infections and antibiotic therapy. Otolaryngol Clin North Am 44, 57-78, v. (2011). 80
52. Li, H., Yang, S., Xiang, J., and Chen, H. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma: does lymph node yield matter? Dis Esophagus 24, 108. (2011).
53. Li, Y., Liu, W., Fang, L., Nan, J., Zhang, Z., and Zhou, Q. [Chemokine receptor 7 induces metastasis of NSCLC via upregulating MMP-9 expression]. Zhongguo Fei Ai Za Zhi 13, 1016-1020. (2010).
54. Liao, X. B., Peng, Y. Q., Zhou, X. M., Yang, B., Zheng, Z., Liu, L. M., Song, F. L., Li, J. M., Zhou, K., Meng, J. C., et al. Taurine restores Axl/Gas6 expression in vascular smooth muscle cell calcification model. Amino Acids 39, 375-383. (2010).
55. Linger, R. M., Keating, A. K., Earp, H. S., and Graham, D. K. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 100, 35-83. (2008).
56. Liu, E., Hjelle, B., and Bishop, J. M. Transforming genes in chronic myelogenous leukemia. Proc Natl Acad Sci U S A 85, 1952-1956. (1988).
57. Liu, Q., Wang, Y. D., Jing, S. H., Wang, X. L., Cheng, Y. J., and Wu, F. P. [Expression of E-cadherin in nasopharyngeal carcinoma and its relationship with cervical lymph node metastasis]. Zhonghua Zhong Liu Za Zhi 32, 425-428. (2010).
58. Lu, Y., Yu, Q., Liu, J. H., Zhang, J., Wang, H., Koul, D., McMurray, J. S., Fang, X., Yung, W. K., Siminovitch, K. A., and Mills, G. B. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem 278,
40057-40066. (2003).
59. Luo, H., Hao, X., Ge, C., Zhao, F., Zhu, M., Chen, T., Yao, M., He, X., and Li, J. TC21 promotes cell motility and metastasis by regulating the expression of E-cadherin and N-cadherin in hepatocellular carcinoma. Int J Oncol 37, 853-859. (2010a).
60. Luo, Y., Ohmori, H., Fujii, K., Chihara, Y., Maruyama, S., and Kuniyasu, H. High matrix metalloproteinase-to-E-cadherin ratio measured by bicolor fluorescent in situ hybridization is associated with lymphangiogenesis and lymph node metastasis in prostate cancer.
Urol Oncol. (2010b)
61. Mak, H. H., Peschard, P., Lin, T., Naujokas, M. A., Zuo, D., and Park, 81 M. Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway. Oncogene 26, 7213-7221. (2007).
62. Manfioletti, G., Brancolini, C., Avanzi, G., and Schneider, C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a
negative coregulator in the blood coagulation cascade. Mol Cell Biol 13, 4976-4985. (1993).
63. Meurman, J. H., and Scully, C. Oral cancer: comprehending the condition, causes, controversies, control and consequences. 3. Other risk factors. Dent Update 38, 66-68. (2011)
64. Mingot, J. M., Vega, S., Maestro, B., Sanz, J. M., and Nieto, M. A. Characterization of Snail nuclear import pathways as representatives of C2H2 zinc finger transcription factors. J Cell Sci 122, 1452-1460. (2009).
65. Mishra, P., Senthivinayagam, S., Rana, A., and Rana, B. Glycogen Synthase Kinase-3beta regulates Snail and beta-catenin during gastrin-induced migration of gastric cancer cells. J Mol Signal 5, 9.
(2010).
66. Mudduluru, G., Ceppi, P., Kumarswamy, R., Scagliotti, G. V., Papotti, M., and Allgayer, H.Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene. (2011).
67. Muller-Rover, S., Tokura, Y., Welker, P., Furukawa, F., Wakita, H., Takigawa, M., and Paus, R. E- and P-cadherin expression during murine hair follicle morphogenesis and cycling. Exp Dermatol 8,
237-246. (1999).
68. Nakano, T. [Gas6: a ligand for receptor tyrosine kinase containing gamma-carboxyglutamic acids]. Seikagaku 68, 299-302. (1996).
69. Nguyen, P. T., Kudo, Y., Yoshida, M., Iizuka, S., Ogawa, I., and Takata, T. N-cadherin expression is correlated with metastasis of spindle cell carcinoma of head and neck region. J Oral Pathol Med 40, 77-82. (2011).
70. Nishimura, E. K., Yoshida, H., Kunisada, T., and Nishikawa, S. I. Regulation of E- and P-cadherin expression correlated with melanocyte migration and diversification. Dev Biol 215, 155-166. (1999).
71. O'Bryan, J. P., Frye, R. A., Cogswell, P. C., Neubauer, A., Kitch, B., 82 Prokop, C., Espinosa, R., 3rd, Le Beau, M. M., Earp, H. S., and Liu, E. T. axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11, 5016-5031. (1991).
72. Orlandi, F., Chiefari, E., Caraci, P., Mussa, A., Gonzatto, I., De Giuli, P., Giuffrida, D., Angeli, A., and Filetti, S. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma. J Endocrinol Invest 24, 51-55. (2001).
73. Oshima, T., Takenoshita, S., Akaike, M., Kunisaki, C., Fujii, S., Nozaki, A., Numata, K., Shiozawa, M., Rino, Y., Tanaka, K., et al. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep. (2011).
74. Ottinger, E. A., Botfield, M. C., and Shoelson, S. E. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J Biol Chem 273, 729-735. (1998).
75. Ou, W. B., Corson, J. M., Flynn, D. L., Lu, W. P., Wise, S. C., Bueno, R., Sugarbaker, D. J., and Fletcher, J. A. AXL regulates mesothelioma proliferation and invasiveness. Oncogene. (2010).
76. Perrone, F., Jocolle, G., Pennati, M., Deraco, M., Baratti, D., Brich, S., Orsenigo, M.,Tarantino, E., De Marco, C., Bertan, C., et al. Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. Eur J Cancer 46, 2837-2848. (2010).
77. Qingxian, L., Qiutang, L., and Qingjun, L. Regulation of phagocytosis by TAM receptors and their ligands. Front Biol 5, 227-237. (2010).
78. Rachagani, S., Senapati, S., Chakraborty, S., Ponnusamy, M. P., Kumar, S., Smith, L. M., Jain, M., and Batra, S. K. Activated Kras(G12D) is associated with invasion and metastasis of pancreatic
cancer cells through inhibition of E-cadherin. Br J Cancer 104, 1038-1048. (2011).
79. Raffel, C., Frederick, L., O'Fallon, J. R., Atherton-Skaff, P., Perry, A., Jenkins, R. B., and James, C. D. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res 5, 4085-4090. (1999).
80. Rankin, E. B., Fuh, K. C., Taylor, T. E., Krieg, A. J., Musser, M., Yuan, J., Wei, K., Kuo, C. J., Longacre, T. A., and Giaccia, A. J. AXL is an essential factor and therapeutic target for metastatic ovarian cancer. 83 Cancer Res 70, 7570-7579. (2010).
81. Robinson, D. R., Wu, Y. M., and Lin, S. F. (2000). The protein tyrosine kinase family of the human genome. Oncogene 19, 5548-5557. (2000).
82. Rojiani, M. V., Alidina, J., Esposito, N., and Rojiani, A. M. Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp Pathol 3, 775-781. (2010).
83. Satahoo-Dawes, S., Palmer, J., Iii, E. W., and Levi, J. Breast and lung metastasis from pancreatic neuroendocrine carcinoma. World J Radiol 3, 32-37. (2011).
84. Sethi, S., Macoska, J., Chen, W., and Sarkar, F. H. Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res 3, 90-99. (2010).
85. Sharif, M. N., Sosic, D., Rothlin, C. V., Kelly, E., Lemke, G., Olson, E. N., and Ivashkiv, L. B. Twist mediates suppression of inflammation by type I IFNs and Axl. J Exp Med 203, 1891-1901. (2006).
86. Shia, C. S., Suresh, G., Hou, Y. C., Lin, Y. C., Chao, P. D., and Juang, S. H. Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: an ex vivo
approach. J Ethnopharmacol 133, 426-433. (2011).
87. Shieh, Y. S., Lai, C. Y., Kao, Y. R., Shiah, S. G., Chu, Y. W., Lee, H. S., and Wu, C. W. Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia 7, 1058-1064. (2005).
88. Shiozawa, Y., Pedersen, E. A., Patel, L. R., Ziegler, A. M., Havens, A. M., Jung, Y., Wang, J., Zalucha, S., Loberg, R. D., Pienta, K. J., and Taichman, R. S. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. Neoplasia 12,
116-127. (2010).
89. Stitt, T. N., Conn, G., Gore, M., Lai, C., Bruno, J., Radziejewski, C., Mattsson, K., Fisher, J., Gies, D. R., Jones, P. F., and et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 80, 661-670. (1995).
90. Suh, C. H., Hilliard, B., Li, S., Merrill, J. T., and Cohen, P. L. TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res Ther 12, R146. (2010).
91. Sun, W., Fujimoto, J., and Tamaya, T. Coexpression of Gas6/Axl in 84 human ovarian cancers. Oncology 66, 450-457. (2004)
92. Tai, K. Y., Shieh, Y. S., Lee, C. S., Shiah, S. G., and Wu, C. W. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1. Oncogene 27, 4044-4055. (2008).
93. Tawk, M., Makoukji, J., Belle, M., Fonte, C., Trousson, A., Hawkins, T., Li, H., Ghandour, S., Schumacher, M., and Massaad, C. Wnt/{beta}-Catenin Signaling Is an Essential and Direct Driver of
Myelin Gene Expression and Myelinogenesis. J Neurosci 31, 3729-3742. (2011).
94. Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J. P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., and Ivaska, J. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. (2010).
95. Wang, Q., Diao, X., Sun, J., and Chen, Z. Regulation of VEGF, MMP-9, and metastasis by CXCR4 in a prostate cancer cell line. Cell Biol Int. (2011a).
96. Wang, Q., Lu, Q. J., Xiao, B., Zheng, Y., and Wang, X. M. Expressions of Axl and Tyro-3 receptors are under regulation of nerve growth factor and are involved in differentiation of PC12 cells.
Neurosci Bull 27, 15-22. (2011b).
97. Wang, X. H., Meng, X. W., Sun, X., Liu, B. R., Han, M. Z., Du, Y. J., Song, Y. Y., and Xu, W. Wnt/beta-catenin signaling regulates MAPK and Akt1 expression and growth of hepatocellular carcinoma cells. Neoplasma 58, 239-244. (2011c).
98. Wellner, U. F., Hopt, U. T., and Brabletz, T. [Tumour stem cells and metastasis]. Zentralbl Chir 135, 318-322. (2010).
99. Yamagata, M., Sanes, J. R., and Weiner, J. A. Synaptic adhesion molecules. Curr Opin Cell Biol 15, 621-632. (2003).
100. Yang, C. C., and Wolf, D. A. Inflamed snail speeds metastasis. Cancer Cell 15, 355-357. (2009)
101. Zhang, Q. K., Boast, S., de los Santos, K., Begemann, M., and Goff, S. P. Transforming activity of retroviral genomes encoding Gag-Axl fusion proteins. J Virol 70, 8089-8097. (1996).
102. Zheng, Y., Zhang, L., Lu, Q., Wang, X., and Yu, F. NGF-induced Tyro3 and Axl function as survival factors for differentiating PC12 cells. Biochem Biophys Res Commun 378, 371-375. (2009).
103. Zhong, Z., Wang, Y., Guo, H., Sagare, A., Fernandez, J. A., Bell, R. D., Barrett, T. M., Griffin, J. H., Freeman, R. S., and Zlokovic, B. V. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway through its sex hormone-binding globulin-like region. J Neurosci 30, 15521-15534. (2010).
104. Zygogianni, A. G., Kyrgias, G., Karakitsos, P., Psyrri, A., Kouvaris, J., Kelekis, N., and Kouloulias, V. Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head
Neck Oncol 3, 2. (2011).
|